Here, we aim to determine the relation of differential DNA methylation and fasting glucose and insulin metabolism as markers of early stages of diabetes pathology in non-diabetic subjects, accounting for obesity measured as body mass index (BMI). This evidence concerns the gene INS and obesity disorder.